Prefrontal brain stimulation to reduce post-stroke fatigue and improve aphasia
Official title: Pre-Frontal tDCS as a Novel Intervention to Reduce Effects of Post-Stroke Fatigue While Improving Language and Attention in Aphasia
Run by Syracuse University · NCT07151677 · Data updated 2026-11-12
This trial tests whether mild electrical stimulation (tDCS) to the front of the brain combined with speech therapy can reduce fatigue and improve language and attention in people with chronic left-hemisphere ischemic stroke and mild-to-moderate aphasia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Syracuse University Academic / other |
| Locations | 2 sites (Ann Arbor, Michigan and 1 other locations) |
| Status | Recruiting |
| Started | August 4, 2025 |
| Main results expected | September 2029 |
| Study ends | November 2029 |
| Registry record updated | September 30, 2026 |
| Trial ID | NCT07151677 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults at least 6 months after a single left-hemisphere ischemic stroke with mild-to-moderate aphasia, self-reported post-stroke fatigue, intact left dorsolateral prefrontal cortex, no recent seizures, and no contraindicating implants or concurrent targeted speech therapy.
✕Probably not a fit
People with severe aphasia, bilateral or non-ischemic strokes, damage overlapping the targeted left DLPFC, recent seizures, uncontrolled neurological or psychiatric conditions, or contraindicated implants/pacemakers (or pregnancy) are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with chronic left-hemisphere ischemic stroke, mild-to-moderate aphasia, and self-reported fatigue are randomized to receive either active transcranial direct current stimulation (tDCS) to prefrontal areas or sham stimulation alongside sentence-comprehension speech therapy. Participants complete standardized fatigue, language (WAB-R or QAB), and cognitive testing before and after 10 treatment sessions. The study compares active versus sham stimulation to see if active tDCS produces greater reductions in fatigue and improvements in language and attention. Researchers will also analyze which participant characteristics are associated with better response to the combined intervention.
Why it matters
Potential benefit: If successful, this could provide a noninvasive, low-risk option to lessen post-stroke fatigue and improve language and attention when paired with speech therapy.
How similar studies have gone: Previous small randomized and pilot studies of tDCS for post-stroke language and fatigue have shown mixed but promising results, so this builds on pilot data rather than representing an untested approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years or older. 2. No diagnosis of neurological disorder (other than stroke). 3. No diagnosis of psychiatric disorder, with the exception of anxiety and/or depression if it is managed through medication and/or behavioral intervention. 4. No seizure within the past 6 months. 5. Not pregnant. 6. Does not currently have cardiac pacemaker 7. In chronic phase of recovery, defined as at least 6 months post-stroke. 8. Not undergoing speech and language therapy targeting auditory comprehension or attention for the duration of the study. 9. No metal implants in the scalp or bone in the pre-frontal area of the head. 10. No unhealed skull fractures. 11. Onset of aphasia related to single, left hemisphere, ischemic stroke. 12. Damaged brain tissue from stroke does not overlap with left hemisphere dorsolateral prefrontal cortex. 13. Mild to moderate aphasia (as measured by WAB-R \*\*or QAB). 14. Self-report of post-stroke fatigue (as measured on SF-CAT) 15. No significant challenges with vision or hearing (with use of corrective aids if needed; eyeglasses, hearing aids). 16. Willing to allow audio-recording of study sessions. Exclusion Criteria: 1. Younger than 18 years old. 2. Diagnosis or history of neurological disorder other than stroke. 3. Diagnosis or history of psychiatric disorder with the exception of anxiety and/or depression if it is managed through medication and/or behavioral intervention. 4. History of seizures within the past 6 months. 5. Pregnant. 6. Currently has cardiac pacemaker 7. \<6 months post-stroke (however, if this is only exclusionary criterion met, participant can be re-evaluated at the 6-month mark if still interested in the study) 8. Currently undergoing speech and language therapy targeting auditory comprehension or attention. 9. Metal implants in the scalp or bone in the pre-frontal area of the head. 10. Currently has an unhealed skull fracture. 11. Onset of aphasia related to etiology other than ischemic left hemisphere stroke. 12. Damaged brain tissue significantly overlaps with left hemisphere dorsolateral prefrontal cortex. 13. No aphasia or severe aphasia (as measured by WAB-R \*\*or QAB). 14. Does not report experience of post-stroke fatigue (as measured on SF-CAT) 15. Significant challenges with vision and/or hearing (even with use of corrective aids). 16. Unwilling to allow audio-recording of study sessions.
Where it's running
-
Syracuse University
Syracuse, New York, United States Recruiting -
University of Michigan
Ann Arbor, Michigan, United States Not yet recruiting
Study contacts
- Study coordinator: Ellyn Riley
- Email: aphasia@syr.edu
- Phone: 315-443-8688
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Paired VNS: How the Brain and Pupils Respond in Stroke Patients
This study tests real-time physiologic responses to paired VNS in adults with chronic motor impairment after ischemic stroke to help tailor dosing.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
-
NeuroAiD test in mild to moderate ischemic stroke patients
This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
-
Understanding how GIM residents’ well-being relates to their careers over time
This study tests how burnout, depression, sleep problems, stress, and fatigue among general internal medicine residents relate to their future career paths.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.